Why the study?
Are plasma endotoxin concentrations during cardiopulmonary bypass related to the type of cardiac surgery and postoperative complications in high-risk adults?
Are plasma endotoxin concentrations during cardiopulmonary bypass related to the type of cardiac surgery and postoperative complications in high-risk adults?
Endotoxemia during cardiopulmonary bypass is higher in procedures involving coronary artery bypass grafting compared to isolated valve replacement, and correlates with the number of grafts and postoperative gastrointestinal dysfunction.
Endotoxin elevation in CABG procedures may signal higher risk; leaves open whether targeted reduction improves outcomes.
Systemic endotoxemia develops during cardiopulmonary bypass, probably due to intestinal ischaemia. Differences in endotoxaemia among various cardiac operations and the relationship between endotoxemia and postoperative complications were studied in high-risk patients. Blood samples were obtained at termination of bypass in 136 adults undergoing elective cardiac surgery. Postoperative complications were registered prospectively. Plasma endotoxin was quantified by a kinetic limulus amebocyte lysate assay. Mean endotoxin concentrations were significantly lower in patients undergoing isolated valve replacement (89 ng/l) than in patients undergoing coronary artery bypass grafting alone (234 ng/l), or combined with valve replacement (278 ng/l) or carotid artery surgery (321 ng/l) (p < 0.05). In multivariate linear regression, only the number of grafts (0, 1-3, 4-5) was significantly correlated to endotoxin concentrations (p < 0.0005). Endotoxin concentrations were related to development of gastrointestinal dysfunction (p = 0.03), but not to mortality (p = 0.24) or other complications (p = 0.62).
No takes yet. Share an insight, caveat, or question.
Videm et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: